Drug manufacturer, Alembic Pharmaceuticals informed the exchanges on Friday that it had secured approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg.